FDA Compliance Program Guidance Manual, Transmittal No. 00-07, January 3, 2000

FDA Compliance Program Guidance Manual, Transmittal No. 00-07, January 3, 2000 PDF Author:
Publisher:
ISBN:
Category :
Languages : en
Pages : 56

Get Book Here

Book Description


FDA Investigations Operations Manual

FDA Investigations Operations Manual PDF Author: Food and Drug Administration
Publisher:
ISBN: 9780865879737
Category : Drugs
Languages : en
Pages : 0

Get Book Here

Book Description
Available now to FDA-regulated organizations, this manual allows facility managers to look at their operation's regulatory compliance through the eyes of the government. Because this is the primary reference manual used by FDA personnel to conduct field investigation activities, you can feel confident you are preparing appropriate planning or action. This manual includes revised instructions regarding the release of information and covers FDA's policies and expectations on a comprehensive range of topics: FDA's authority to enter and inspect, inspection notification, detailed inspection procedures, recall monitoring, inspecting import procedures, computerized data requests, federal/state inspection relationships, discussions with management regarding privileged information, seizure and prosecution, HACCP, bioengineered food, dietary supplements, cosmetics, bioterrorism, and product disposition. The manual also includes a directory of Office of Regulatory Affairs offices and divisions.

The CMS Hospital Conditions of Participation and Interpretive Guidelines

The CMS Hospital Conditions of Participation and Interpretive Guidelines PDF Author:
Publisher:
ISBN: 9781683086857
Category :
Languages : en
Pages : 546

Get Book Here

Book Description
In addition to reprinting the PDF of the CMS CoPs and Interpretive Guidelines, we include key Survey and Certification memos that CMS has issued to announced changes to the emergency preparedness final rule, fire and smoke door annual testing requirements, survey team composition and investigation of complaints, infection control screenings, and legionella risk reduction.

Registries for Evaluating Patient Outcomes

Registries for Evaluating Patient Outcomes PDF Author: Agency for Healthcare Research and Quality/AHRQ
Publisher: Government Printing Office
ISBN: 1587634333
Category : Medical
Languages : en
Pages : 385

Get Book Here

Book Description
This User’s Guide is intended to support the design, implementation, analysis, interpretation, and quality evaluation of registries created to increase understanding of patient outcomes. For the purposes of this guide, a patient registry is an organized system that uses observational study methods to collect uniform data (clinical and other) to evaluate specified outcomes for a population defined by a particular disease, condition, or exposure, and that serves one or more predetermined scientific, clinical, or policy purposes. A registry database is a file (or files) derived from the registry. Although registries can serve many purposes, this guide focuses on registries created for one or more of the following purposes: to describe the natural history of disease, to determine clinical effectiveness or cost-effectiveness of health care products and services, to measure or monitor safety and harm, and/or to measure quality of care. Registries are classified according to how their populations are defined. For example, product registries include patients who have been exposed to biopharmaceutical products or medical devices. Health services registries consist of patients who have had a common procedure, clinical encounter, or hospitalization. Disease or condition registries are defined by patients having the same diagnosis, such as cystic fibrosis or heart failure. The User’s Guide was created by researchers affiliated with AHRQ’s Effective Health Care Program, particularly those who participated in AHRQ’s DEcIDE (Developing Evidence to Inform Decisions About Effectiveness) program. Chapters were subject to multiple internal and external independent reviews.

United States Attorneys' Manual

United States Attorneys' Manual PDF Author: United States. Department of Justice
Publisher:
ISBN:
Category : Justice, Administration of
Languages : en
Pages : 720

Get Book Here

Book Description


Freedom of Information Act Guide

Freedom of Information Act Guide PDF Author:
Publisher:
ISBN:
Category : Freedom of information
Languages : en
Pages : 1154

Get Book Here

Book Description


ORI Introduction to the Responsible Conduct of Research

ORI Introduction to the Responsible Conduct of Research PDF Author: Nicholas Hans Steneck
Publisher:
ISBN:
Category : Medicine
Languages : en
Pages : 184

Get Book Here

Book Description


Technical Support Document for Water Quality-based Toxics Control

Technical Support Document for Water Quality-based Toxics Control PDF Author: United States. Environmental Protection Agency. Office of Water
Publisher:
ISBN:
Category : Toxicology
Languages : en
Pages : 344

Get Book Here

Book Description


Canada Enters the Nuclear Age

Canada Enters the Nuclear Age PDF Author: Atomic Energy of Canada Limited
Publisher: McGill-Queen's Press - MQUP
ISBN: 9780773516014
Category : Business & Economics
Languages : en
Pages : 466

Get Book Here

Book Description
The nuclear energy company has overseen the production of its own history, focusing on programs at its laboratories in Chalk River, Ontario, and Whiteshell, Manitoba between 1943 and 1985. The 16 scientists who wrote the narrative discuss the organization and operations of the laboratories, nuclear safety and radiation protection, radioisotopes, basic research, developing the CANDU reactor, managing the radioactive wastes, business development, and revenue generation. Canadian card order number: C97-900188-9. Annotation copyrighted by Book News, Inc., Portland, OR

Guidelines on Representative Drug Sampling

Guidelines on Representative Drug Sampling PDF Author: United Nations
Publisher: United Nations Publications
ISBN: 9789211482416
Category : Business & Economics
Languages : en
Pages : 44

Get Book Here

Book Description
The present guidelines describe a number of sampling methods, from arbitrary methods with a statistical background. They focus on sampling in cases where large numbers of relatively homogeneous material are available. They do not deal with so-called tactical sampling, which may be applied for house-searches or in clandestine laboratory investigations. Its aim is to support drug analysis laboratories in the selection of their sampling strategies and best working practices.